The current study adds to the growing body of evidence indicating that tumor-stroma interactions are of significant importance in breast cancer, and specifically these data indicate that resistin may act via mechanistically distinct pathways from those previously discovered using tumor cell models alone in isolation. The gene discussed is RETN; the disease is breast carcinoma.